Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant
Patients after autologous (autoSCT) and allogeneic stem cell transplantation (alloSCT) are at Decorative Plates an increased risk of COVID-19-related morbidity and mortality, compounded by an immune system weakened by the underlying malignancy and prior treatments.Allogeneic transplantation, including stem cell and solid organ transplants, requires